Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17779739 | 0.85 | — | — | |
| SCHEMBL17324163 | 0.85 | — | — | |
| SCHEMBL15468507 | 0.82 | — | — | |
| SCHEMBL890401 | 0.77 | — | — | |
| SCHEMBL16473068 | 0.77 | — | — | |
| SCHEMBL12603950 | 0.77 | — | — | |
| SCHEMBL14561703 | 0.75 | — | — | |
| SCHEMBL1029486 | 0.75 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL14231624 | 0.75 | — | — | |
| SCHEMBL10040943 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10899692-B2 | Purification method and production method of difluoromethyl-1, 2, 2, 2-tetrafluoroethyl ether | CENTRAL GLASS COMPANY, LIMITED (JP) | 2021-01-26 | — | — | US | claimed |
| US-20200339494-A1 | Purification Method and Production Method of Difluoromethyl-1, 2, 2, 2-Tetrafluoroethyl Ether | CENTRAL GLASS COMPANY, LIMITED (JP) | 2020-10-29 | — | — | US | claimed |
| CN-111556859-A | Method for purifying difluoromethyl-1, 2,2, 2-tetrafluoroethyl ether and process for producing the same | 中央硝子株式会社 | 2020-08-18 | — | — | CN | claimed |
| CN-101535231-B | Process for the preparation of chloromethyl 2,2,2-trifluoro-1-(trifluoromethyl) ethyl ether | CRISTALIA PROD QUIMICOS FARM | 2012-12-19 | — | — | CN | claimed |
| CN-101314560-B | Process for synthesizing Sevoflurane | LUNAN PHARM GROUP CORP | 2011-06-15 | — | — | CN | claimed |
| CN-101535231-A | Process for the preparation of chloromethyl 2,2,2-trifluoro-1-(trifluoromethyl) ethyl ether | CRISTALIA PROD QUIMICOS FARM | 2009-09-16 | — | — | CN | claimed |
| CN-101314560-A | Process for synthesizing Sevoflurane | LUNAN PHARM GROUP CORP (CN) | 2008-12-03 | — | — | CN | claimed |
| JP-3252391-B2 | — | — | 2002-02-04 | — | — | JP | claimed |
| EP-0642486-B1 | PRODUCTION OF HYDROFLUOROCARBONS FROM alpha-FLUOROETHERS AND SOME alpha-FLUOROETHERS | ICI PLC (GB) | 1999-06-02 | — | — | EP | claimed |
| EP-0642486-A1 | PRODUCTION OF HYDROFLUOROCARBONS FROM $g(a)-FLUOROETHERS AND $g(a)-FLUOROETHERS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1995-03-15 | — | — | EP | claimed |
| WO-1993012057-A1 | PRODUCTION OF HYDROFLUOROCARBONS FROM α-FLUOROETHERS AND α-FLUOROETHERS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1993-06-24 | — | — | WO | claimed |
| WO-2023157441-A1 | ETCHING METHOD | 株式会社レゾナック | 2023-08-24 | — | — | WO | disclosed |
| CN-111556859-B | Method for purifying difluoromethyl-1, 2-tetrafluoroethyl ether and process for producing the same | 中央硝子株式会社 | 2022-10-25 | — | — | CN | disclosed |
| US-10899692-B2 | Purification method and production method of difluoromethyl-1, 2, 2, 2-tetrafluoroethyl ether | CENTRAL GLASS COMPANY, LIMITED (JP) | 2021-01-26 | — | — | US | disclosed |
| US-20200339494-A1 | Purification Method and Production Method of Difluoromethyl-1, 2, 2, 2-Tetrafluoroethyl Ether | CENTRAL GLASS COMPANY, LIMITED (JP) | 2020-10-29 | — | — | US | disclosed |
| US-5696308-A | HEATING AN ALPHA-FLUOROETHER IN THE VAPOR PHASE WITH HYDROGEN FLUORIDE IN THE PRESENCE OF A CATALYST | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1997-12-09 | — | — | US | disclosed |
| US-5637776-A | ACYCLIC FLUORINATED ETHER | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1997-06-10 | — | — | US | disclosed |
| US-5504263-A | HEATING ALPHA-FLUOROETHER IN VAPOR PHASE AT ELEVATED TEMPERATURE INPRESENCE OF HYDROGEN FLUORIDE AND CATALYST | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1996-04-02 | — | — | US | disclosed |
| EP-0642486-A1 | PRODUCTION OF HYDROFLUOROCARBONS FROM $g(a)-FLUOROETHERS AND $g(a)-FLUOROETHERS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1995-03-15 | — | — | EP | disclosed |
| WO-1993012057-A1 | PRODUCTION OF HYDROFLUOROCARBONS FROM α-FLUOROETHERS AND α-FLUOROETHERS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1993-06-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200339494-A1 | Purification Method and Production Method of Difluoromethyl-1, 2, 2, 2-Tetrafluoroethyl Ether | TDO2, PBRM1, AFF1 | ALDH1A1 1290/4885 |
| US-10899692-B2 | Purification method and production method of difluoromethyl-1, 2, 2, 2-tetrafluoroethyl ether | TDO2, PBRM1, AFF1 | ALDH1A1 1290/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.